Literature DB >> 21048370

Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza A (H1N1) vaccination.

Yukihiro Umeda1, Miwa Morikawa, Masaki Anzai, Yasuyuki Sumida, Maiko Kadowaki, Shingo Ameshima, Takeshi Ishizaki.   

Abstract

We report a case of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) after pandemic influenza (H1N1) vaccination. A 57-year-old man, who had been diagnosed with IPF in September 2008, was admitted to our hospital in December 2009 because of aggravation of dyspnea and fever two days after H1N1 vaccination. Chest computed tomography showed diffuse bilateral ground-glass opacities superimposed on preceding reticular opacities. We diagnosed AE-IPF. Corticosteroid and cyclophosphamide were effective. Although the efficacy of influenza vaccination in patients with chronic lung diseases is well established, physicians should keep in mind that influenza vaccination has the potential to cause AE-IPF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048370     DOI: 10.2169/internalmedicine.49.3890

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  16 in total

1.  Leucocytoclastic vasculitis following influenza vaccination.

Authors:  Sissi Cao; Dongmei Sun
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  PD-1hi CD8+ resident memory T cells balance immunity and fibrotic sequelae.

Authors:  Zheng Wang; Shaohua Wang; Nick P Goplen; Chaofan Li; In Su Cheon; Qigang Dai; Su Huang; Jinjun Shan; Chaoyu Ma; Zhenqing Ye; Min Xiang; Andrew H Limper; Eva-Carmona Porquera; Jacob E Kohlmeier; Mark H Kaplan; Nu Zhang; Aaron J Johnson; Robert Vassallo; Jie Sun
Journal:  Sci Immunol       Date:  2019-06-14

Review 3.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis.

Authors:  Shanna L Ashley; Yangjin Jegal; Thomas A Moore; Linda F van Dyk; Yasmina Laouar; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-30       Impact factor: 5.464

5.  Interstitial Lung Disease and Transverse Myelitis: A Possible Complication of COVID-19 Vaccine.

Authors:  Zunaira Khan; Ahmad Ammar Khattak; Nawal Rafiq; Anam Amin; Mahwish Abdullah
Journal:  Cureus       Date:  2022-02-03

6.  Interstitial Pneumonia Associated with the Influenza Vaccine: A Report of Two Cases.

Authors:  Makoto Hibino; Tetsuri Kondo
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

7.  The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Dong Weng; Xian-Qiu Chen; Hui Qiu; Yuan Zhang; Qiu-Hong Li; Meng-Meng Zhao; Qin Wu; Tao Chen; Yang Hu; Liu-Sheng Wang; Ya-Ru Wei; Yu-Kui Du; Shan-Shan Chen; Ying Zhou; Fen Zhang; Li Shen; Yi-Liang Su; Martin Kolb; Hui-Ping Li
Journal:  Mediators Inflamm       Date:  2019-01-03       Impact factor: 4.711

Review 8.  "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.

Authors:  Radu Crisan-Dabija; Cristina Alice Pavel; Iolanda Valentina Popa; Andrei Tarus; Alexandru Burlacu
Journal:  J Proteome Res       Date:  2020-09-17       Impact factor: 4.466

Review 9.  Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategies.

Authors:  Pooja Shivshankar
Journal:  ISRN Inflamm       Date:  2012-05-17

Review 10.  The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Paolo Spagnolo; Philip L Molyneaux; Nicol Bernardinello; Elisabetta Cocconcelli; Davide Biondini; Federico Fracasso; Mariaenrica Tiné; Marina Saetta; Toby M Maher; Elisabetta Balestro
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.